ASH | American Society of Hematology Meeting & Exposition
ASH 2023
ASH 2022
Superior efficacy of Iptacopan in PNH patients
/ Régis Peffault De Latour
CLL – Update from ASH 2022
/ Carsten Utoft Niemann
New potential key pathway in patients with ALL
/ Signe Modvig
ASH 2021
Update om behandling af myelomatose med bispecifikke antitoffer
/ Agoston Gyula Szabos
CAR-T-terapi til behandling av storcellet B-cellelymfom
/ Alexander Fosså
Relapse vaccine is a promising treatment for patients with AML
/ Bjørn Tore Gjertsen